Share this publication:
Hypertension is a part of metabolic syndrome affecting millions of people across the globe. Though early detection and timely meditation decreases the chances of Coronary-Vascular-Disease (CVD) and angiopathies which increases the life expectancy, but the Resistant Hypertension is increasing which reduces the overall morbidity and mortality. Hence detecting newer targets and to supplement mainline therapy is essential to control the everincreasing Hypertension.
About the publisher:
iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.